Cover Image
市场调查报告书

末梢神经病变性疼痛:全球临床实验趋势

Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2018

出版商 GlobalData 商品编码 309552
出版日期 内容信息 英文 125 Pages
订单完成后即时交付
价格
Back to Top
末梢神经病变性疼痛:全球临床实验趋势 Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2018
出版日期: 2018年04月30日 内容信息: 英文 125 Pages
简介

本报告提供末梢神经病变性疼痛治疗药相关之临床实验最新趋势分析,提供您G7(主要7国)及E7(新兴7国)的临床实验数量,受验人数,并汇整有潜力的赞助商,临床实验主要参与企业和机关,有潜力的药剂等信息。

本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要5国的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲主要国家的临床实验数量
    • 中南美主要5国的临床实验数量

G7各国临床实验数量:中枢神经系统疾病治疗药临床实验上末梢神经病变性疼痛的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

E7各国临床实验数量:中枢神经系统疾病治疗药临床实验上末梢神经病变性疼痛的比例

E7各国的各阶段临床实验数量

E7各国临床实验数量:各进展状况

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

一定期间所采用的实验对像

赞助商类别的临床实验数量

有潜力的赞助商

末梢神经病变性疼痛治疗药临床实验主要的参与企业

有潜力的药剂

临床实验简介概要

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC4960CTIDB

GlobalData's clinical trial report, "Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2018" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Peripheral Neuropathic Pain Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 123

  • Abbreviations 123
  • Definitions 123
  • Research Methodology 124
  • Secondary Research 124
  • About GlobalData 125
  • Contact Us 125
  • Source 125

List of Tables

List of Tables

  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
  • Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
  • Peripheral Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Peripheral Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
  • Peripheral Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Peripheral Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2018* 21
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Peripheral Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures

List of Figures

  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
  • Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018* 15
  • Peripheral Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
  • Peripheral Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
  • Proportion of Peripheral Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018* 18
  • Peripheral Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
  • Peripheral Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
  • Peripheral Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
  • Peripheral Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
  • Peripheral Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
  • GlobalData Methodology 124
Back to Top